SCHEMBL19667963

SCHEMBL19667963

CCOC(=O)c1csc(Nc2cc(F)cc(F)c2)n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.62
NPSR1 Q6W5P4 3/20 0.62
TDP1 Q9NUW8 3/20 0.62
LMNA P02545 2/20 0.62
KDM4E B2RXH2 2/20 0.62
CYP1A2 P05177 1/20 0.59
CYP2C19 P33261 1/20 0.59
SMN1; SMN2 Q16637 5/20 0.56
GAA P10253 2/20 0.56
RAB9A P51151 5/20 0.53
NPC1 O15118 4/20 0.53
HSD17B10 Q99714 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.52
HPGD P15428 1/20 0.51
TSHR P16473 1/20 0.51
EGFR P00533 1/20 0.51
CA12 O43570 3/20 0.50
CA1 P00915 3/20 0.50
CA2 P00918 3/20 0.50
CA9 Q16790 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10464406 0.87 MAPT (0.65) MAPTNPSR1TDP1LMNAKDM4E
SCHEMBL21708007 0.84 CYP1A2 (0.55) MAPTNPSR1TDP1LMNAKDM4E
SCHEMBL21708021 0.82 MAPT (0.68) MAPTNPSR1TDP1LMNAKDM4E
SCHEMBL4789312 0.82 SMN1; SMN2 (0.69) MAPTNPSR1TDP1LMNAKDM4E
SCHEMBL2831045 0.81 L3MBTL1 (0.62) MAPTNPSR1TDP1LMNAKDM4E
SCHEMBL9647639 0.81 CYP1A2 (0.54) MAPTNPSR1TDP1LMNAKDM4E
SCHEMBL21708015 0.81 MAPT (0.67) MAPTNPSR1TDP1LMNAKDM4E
SCHEMBL21708013 0.81 MAPT (0.67) MAPTNPSR1TDP1LMNAKDM4E
SCHEMBL525606 0.81 MAOA (0.64) MAPTNPSR1TDP1LMNAKDM4E
SCHEMBL21708008 0.81 KDM1A (0.67) MAPTNPSR1TDP1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109195966-B Microbiocidal thiazole derivatives 先正达参股股份有限公司 2022-09-16 CN disclosed
EP-3464284-B1 MICROBIOCIDAL THIAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2020-10-21 EP disclosed
US-20200277288-A1 Microbiocidal Thiazole Derivatives SYNGENTA PARTICIPATIONS AG (CH) 2020-09-03 US disclosed
US-10662182-B2 Microbiocidal thiazole derivatives SYNGENTA PARTICIPATIONS AG (CH) 2020-05-26 US disclosed
US-20190330168-A1 MICROBIOCIDAL THIAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2019-10-31 US disclosed
EP-3464284-A1 MICROBIOCIDAL THIAZOLE DERIVATIVES Syngenta Participations AG (CH) 2019-04-10 EP disclosed
CN-109195966-A Kill the thiazole of microorganism 先正达参股股份有限公司 2019-01-11 CN disclosed
WO-2017207362-A1 MICROBIOCIDAL THIAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2017-12-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200277288-A1 Microbiocidal Thiazole Derivatives MSR1, CASP1, TLR1 MAPT 4103/4885NPSR1 2681/4885TDP1 836/4885
US-20190330168-A1 MICROBIOCIDAL THIAZOLE DERIVATIVES MSR1, CASP1, MPO MAPT 4152/4885NPSR1 2831/4885TDP1 1066/4885
US-10662182-B2 Microbiocidal thiazole derivatives MSR1, CASP1, MPO MAPT 4152/4885NPSR1 2831/4885TDP1 1066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.